Home
Account
Research Tools & Data
Educate
Contribute
News
ETFs
Sectors
About
Subscribe
Login
Manage Account
Quote and Research
Stock Charts
Earnings Calendar
Technical Scans
Economic Calendar
Chart School
Tutorials
Learning Center
Submit Article
Join Blog Network
Chat Rooms
Rate Broker
Rate Software
About Us
Contact Us
Advertise With Us
Terms and Conditions
Enter Symbol
Overview
Community Research
Stock Sentiment
Whisper Estimates
Enter Estimates
Company Profile
Technical Charts
Competitors
Analyst Ratings
Analyst Estimates
Sales Estimates
Related News
Blog Articles
Press Releases
Message Board
Option Chain
Financial Ratios
Technicals
SEC Filings
Press Releases
Obagi Medical Products Reports Second Quarter 2009 Financial Results
Obagi Medical Products Reveals Results of a Meta-Analysis Comparing the Company’s Novel 5 Percent Solubilized BPO to Other Prescription 5 Percent BPO and Combination BPO/Clindamycin Topical Products
Obagi Medical Products’ CLENZIderm M.D. Serum Gel Significantly Reduces Non-Inflammatory Lesions with Visible Results as Early as Week One
Obagi Medical Products Releases Results of a Clinical Trial Showing Optimized Patient Outcomes When Condition & Enhance System is Used in Combination with Botulinum Toxin Type A
Obagi Medical Products to Present at the 29th Annual Canaccord Adams Global Growth Conference in August
Obagi Medical Products to Report Second Quarter 2009 Financial Results and Host a Conference Call on August 6
Obagi Medical Products Reports First Quarter 2009 Financial Results
Obagi Medical Products to Report First Quarter 2009 Financial Results and Host a Conference Call on May 7
New Survey Reveals Women Are Still Spending Money on In-Office Procedures and Skin Care Despite Current Economy
Obagi Medical Products, Inc. Focuses on the Physician Dispense Market and Discontinues Distribution in the Pharmacy Channel
New Clinical Data Shows That Obagi Medical Products’ Condition & Enhance System Improves the Results of Intense Pulsed Light Treatments
Obagi Medical Products’ ELASTIderm Décolletage System Reduces Visible Signs of Aging on Chest and Neck
Obagi Medical Products’ CLENZIderm M.D. System Effectively Treats Acne with Visible Results as Early as Two Weeks
Obagi Medical Products to Present at the B. Riley & Co. 2009 Annual Investor Conference in March
Obagi Medical Products Reports Annual Sales Growth and Solid Profitability - Mar 9 2009 11:54AM
Obagi Medical Products Reports Annual Sales Growth and Solid Profitability - Mar 5 2009 8:24AM
Obagi Medical Products to Report Fourth Quarter and Full Year 2008 Financial Results and Host a Conference Call on March 5
Obagi Medical Products to Present at Two Investor Conferences in February and March
Obagi Medical Products Launches the First Complete Therapeutic Prescription-Based Skin Care System to Treat and Manage Rosacea
Obagi Medical Products to Present at Two Investor Conferences in January
Obagi Medical Products Expands Partnership with Japan-Based Rohto Pharmaceutical Co., Ltd.
Obagi Medical Products Reports Third Quarter 2008 Financial Results
Obagi Medical Products to Report Third Quarter 2008 Financial Results and Host a Conference Call on November 6
Obagi Medical Products' ELASTIderm Decolletage System Reduces Visible Signs of Aging on Chest and Neck
Obagi Medical Products to Present at the Maxim Group Growth Conference
Obagi Medical Products to Present at Two Investor Conferences in September
Obagi Medical Products Reports Second Quarter 2008 Financial Results
Obagi Medical Products Launches SoluCLENZ Rx Gel, the Only Prescription Solubilized Benzoyl Peroxide for Acne
Obagi Medical Products Launches National Consumer Awareness Campaign for Its Condition & Enhance System
Obagi Medical Products Presents In Vitro Data Showing Its Topical Vitamin C Serums Provide Greater Absorption and Stability Than a Leading Competitor
Obagi Medical Products' 3-Step Acne System Provides an Effective Approach to Treating Acne without Topical Antibiotic Exposure
Obagi Medical Products Moves Up Time of August 11 Second Quarter 2008 Financial Results and Conference Call To Before Market Open
Obagi Medical Products to Report Second Quarter 2008 Financial Results and Host a Conference Call on August 11
Obagi Medical Products Names Preston Romm Chief Financial Officer
Journal of Drugs in Dermatology Highlights Data Showing the Benefits of Solubilized 5% Benzoyl Peroxide Gel in the Treatment of Acne
Obagi Medical Products to Present at Baird's Growth Stock Conference - Jun 2 2008 12:51AM
Obagi Medical Products Reports First Quarter 2008 Financial Results - Jun 2 2008 12:51AM
Cosmetic Dermatology Publishes Data Highlighting the Benefits of CLENZIderm M.D. Systems for Acne
Landmark Survey Uncovers Reasons Why Women Are Not Able to Properly Address Their Skin Care Issues
Obagi Medical Products to Report First Quarter 2008 Financial Results and Host a Conference Call on May 5
Fundamental data is provided by
Zacks Investment Research
, market data is provided by
AlphaTrade.
, and Commentary and Press Releases provided by
Quotemedia